Highlights Jubilant Pharmova Limited NSE India S.E.

Equities

JUBLPHARMA

INE700A01033

Market Closed - NSE India S.E. Other stock markets 07:40:30 2024-05-21 am EDT			5-day change	1st Jan Change
702.4 ^INR	-2.78%		+2.06%	+28.77%

May. 03	Jubilant Pharmova Appoints CEO for Radiopharma Business	MT
Apr. 25	Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	Apr. 24	MT
Jubilant Pharmova Unit Gets VAI Status for Roorkee, India Facility	Apr. 17	MT
India's Jubilant Pharmova posts quarterly profit	Feb. 02	RE
Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 02	CI
Jubilant Ingrevia Redeems INR1 Billion at Maturity Date	Nov. 15	MT
Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-27	CI
Domino's India operator Jubilant beats Q2 profit estimates on cheaper launches	23-10-25	RE
Ex-dividend day for final dividend	23-08-09	FA
Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2023, Payable on or Before September 29, 2023	23-08-07	CI
Jubilant Pharmova Limited Recommends Dividend for the Financial Year Ended March 31, 2023	23-07-31	CI
Jubilant Pharmova's Consolidated Profit Plunges in Fiscal Q1	23-07-20	MT
Jubilant Pharmova Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-19	CI
Indian shares set for flat start ahead of key earnings	23-07-18	RE
INDIA STOCKS-Indian shares rise to five-month high on improved global cues	23-05-30	RE
Jubilant Pharmova Limited Recommends Dividend for the Financial Year Ended March 31, 2023	23-05-29	CI
Jubilant Pharmova Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-29	CI
Jubilant Pharmanova's Canadian Arm Gets CA$24 Million Loan for Capacity Expansion	23-03-17	MT
Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-03	CI
Jubilant Pharmova Arm Gets US FDA Nod for Technetium Mertiatide Injection	23-01-31	MT
Jubilant Pharmova Gets Eight Observations from US FDA for API Plant in India	22-12-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Jubilant Pharmova Limited NSE India S.E.

Equities

JUBLPHARMA

INE700A01033

Highlights

Filters